Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Journal of Preventive Medicine ; : 60-66, 2008.
Article in Vietnamese | WPRIM | ID: wpr-889

ABSTRACT

Background: Recently, microplate almar blue assay has been used commonly in detecting gen related to tuberculosis drug resistance, which provides results after 5-7 days with lower cost compared to traditional methods. Objective: To evaluate the application of microplate almar blue assay for rapid detection of drug resistance of M. tuberculosis strains. Subject and Method: A microplate-based assay which uses Alamar blue reagent - an oxidation reduction dye (MABA), was used for the determination of the anti-tuberculosis drug (isoniazid-INH, rifampicine-RIF, streptomycine-STR and ethabuton=EMB) resistance of 96 M. tuberculosis strains isolated from Vietnamese patients in comparison to those obtained by conversional method. Result: MABA showed to have high sensitivity and specificity in testing the sensitivity to individual anti-tuberculosis drugs (from 82.4% for STR to 93.3% for - INH and from 82.5% for EMB to 98.4% for STR; respectively), as well as for the multi-drug resistant M.tuberculosis (86.4% of sensitivity), highly correlated with the result determined by proportion method. Conclusion: MABA reveals the advantage in shortening test time, in simple performance and lower cost compared with the conversional culture based methods.


Subject(s)
Drug Resistance
2.
Journal of Preventive Medicine ; : 23-29, 2007.
Article in Vietnamese | WPRIM | ID: wpr-610

ABSTRACT

Background: There are many methods used in epidemiological studies of tuberculosis (TB) bacteria but Spoligotyping method is widely used with high accuracy, simple procedure, and carried out on strains containing a little of IS6110 segment \r\n', u'Objectives: To improve Spoligotyping technique and apply this technique to classify Mycobacterium tuberculosis\r\n', u'Subjects and method: Subjects and methods: The study included 12 medical waste samples collected at Thai Binh Hospital of Tuberculosis and 19 samples obtained from the The Hanoi Institute for Tuberculosis and Lung Diseases. Spoligo model of 31 samples were analyzed based on Spotclust and SpoIDB4 database and divided up into family and subfamily.\r\n', u'Results: Spoligotyping technique has good results with the PCR product amplified 40 cycles and presented the film in 18 hours. Obtained results in 31 medical waste samples belong to 4 families: Beijing, EAI, T1 and H3-LAM9. EAI and Beijing are dominant families with 45.16% and 38.7%), respectively. T1 and H3-LAM9 are 12.9% and 3.22%, respectively. The number of samples in the study is little but the obtained rate of different spoligo models of strains are quite diversified (41.9%)\r\n', u'Conclusion: This result is relatively appropriate with previous studies on the distribution of EAI and Beijing families in Vietnam and the world. Spligotyping technique distinguished samples belonging to Beijing or non-Beijing families, which support for clinical treatment and development of new vaccines.\r\n', u'\r\n', u'\r\n', u'


Subject(s)
Mycobacterium tuberculosis , Tuberculosis
3.
Journal of Vietnamese Medicine ; : 75-79, 1999.
Article in Vietnamese | WPRIM | ID: wpr-3417

ABSTRACT

A study on the prostatic samples from 2 groups of patients with prostatic intra epithelia neoplasia, group I- patients in the post-telecommunication hospital and group II- patients in the Saint Vincent. The researcher found that there was no significant difference of ages between 2 groups, the prostatic hyperplasia frequently occurred in persons with ages of 60-65, while prostatic epitheliama frequently occurred in patients with ages of 80-85. The high grade lesion of prostatic intra epithelial neoplasia in the group I was less than this in the group II. The prostatic intra epithelia neoplasia combining with prostatic epithelioma in the group I was lower than this in group II.


Subject(s)
Prostatic Hyperplasia , Carcinoma
SELECTION OF CITATIONS
SEARCH DETAIL